Literature DB >> 31287657

Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src Kinase.

Michael P Agius1,2, Kristin S Ko3, Taylor K Johnson2, Frank E Kwarcinski2, Sameer Phadke1, Eric J Lachacz1, Matthew B Soellner1,3.   

Abstract

Protein kinase pathways are traditionally mapped by monitoring downstream phosphorylation. Meanwhile, the noncatalytic functions of protein kinases remain under-appreciated as critical components of kinase signaling. c-Src is a protein kinase known to have noncatalytic signaling function important in healthy and disease cell signaling. Large conformational changes in the regulatory domains regulate c-Src's noncatalytic functions. Herein, we demonstrate that changes in the global conformation of c-Src can be monitored using a selective proteolysis methodology. Further, we use this methodology to investigate changes in the global conformation of several clinical and nonclinical mutations of c-Src. Significantly, we identify a novel activating mutation observed clinically, W121R, that can escape down-regulation mechanisms. Our methodology can be expanded to monitor the global conformation of other tyrosine kinases, including c-Abl, and represents an important tool toward the elucidation of the noncatalytic functions of protein kinases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31287657      PMCID: PMC7254491          DOI: 10.1021/acschembio.9b00306

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  43 in total

1.  Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.

Authors:  M A Young; S Gonfloni; G Superti-Furga; B Roux; J Kuriyan
Journal:  Cell       Date:  2001-04-06       Impact factor: 41.582

Review 2.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

Review 3.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition.

Authors:  Egle Avizienyte; Margaret C Frame
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

5.  Kinase domain mutations in cancer: implications for small molecule drug design strategies.

Authors:  Jack A Bikker; Natasja Brooijmans; Allan Wissner; Tarek S Mansour
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

Review 6.  Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

Authors:  T Hunter
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

7.  Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck.

Authors:  Sichuan Xi; Qing Zhang; Kevin F Dyer; Edwina C Lerner; Thomas E Smithgall; William E Gooding; Joanne Kamens; Jennifer Rubin Grandis
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

8.  Overcoming resistance to HER2 inhibitors through state-specific kinase binding.

Authors:  Chris J Novotny; Sirkku Pollari; Jin H Park; Mark A Lemmon; Weijun Shen; Kevan M Shokat
Journal:  Nat Chem Biol       Date:  2016-09-05       Impact factor: 15.040

9.  COSMIC: somatic cancer genetics at high-resolution.

Authors:  Simon A Forbes; David Beare; Harry Boutselakis; Sally Bamford; Nidhi Bindal; John Tate; Charlotte G Cole; Sari Ward; Elisabeth Dawson; Laura Ponting; Raymund Stefancsik; Bhavana Harsha; Chai Yin Kok; Mingming Jia; Harry Jubb; Zbyslaw Sondka; Sam Thompson; Tisham De; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

10.  Activation of tyrosine kinases by mutation of the gatekeeper threonine.

Authors:  Mohammad Azam; Markus A Seeliger; Nathanael S Gray; John Kuriyan; George Q Daley
Journal:  Nat Struct Mol Biol       Date:  2008-09-14       Impact factor: 15.369

View more
  3 in total

1.  How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture.

Authors:  Linglan Fang; Jessica Vilas-Boas; Sujata Chakraborty; Zachary E Potter; Ames C Register; Markus A Seeliger; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2020-06-23       Impact factor: 5.100

2.  Parallel Chemoselective Profiling for Mapping Protein Structure.

Authors:  Zachary E Potter; Ho-Tak Lau; Sujata Chakraborty; Linglan Fang; Miklos Guttman; Shao-En Ong; Douglas M Fowler; Dustin J Maly
Journal:  Cell Chem Biol       Date:  2020-07-09       Impact factor: 8.116

3.  Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase.

Authors:  Taylor K Johnson; Daniel A Bochar; Nathalie M Vandecan; Jessica Furtado; Michael P Agius; Sameer Phadke; Matthew B Soellner
Journal:  Angew Chem Int Ed Engl       Date:  2021-08-11       Impact factor: 16.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.